AZN

AstraZeneca PLC (AZN)

Last Price$74.20.9%
Market Cap$460.2B
LTM Return on Equity (ROE)
20.1%
5Y avg
14.3%
Drug Manufacturers - General industry median
19.9%
Stock quality & Intrinsic value
7/10
(0.6%) overvalued

AstraZeneca PLC Return on Equity (ROE)

Annual
Quarterly
LTM
Industry median
Company stand-alone
AZN
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Return on Equity (ROE)
31.4%
46.1%
56.5%
53.4%
59.0%
40.8%
49.6%
52.8%
32.5%
13.8%
5.8%
16.1%
20.2%
13.4%
13.0%
10.8%
25.9%
(1.0%)
6.6%
18.1%
AZN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for AZN and see if it's the right time to invest.
Dive in

AstraZeneca PLC (AZN) Return on Equity (ROE) comparison analysis

Crunching data... Almost there!

AZN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is AstraZeneca PLC's Return on Equity (ROE)?

As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 20.1%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Equity (ROE) for AstraZeneca PLC have been 11.8% over the past three years, and 15.0% over the past five years.

2) Is AstraZeneca PLC's Return on Equity (ROE) Good?

As of today, AstraZeneca PLC's Return on Equity (ROE) is 20.1%, which is higher than industry median of 19.9%. It indicates that AstraZeneca PLC's Return on Equity (ROE) is Good.

3) How does AstraZeneca PLC's Return on Equity (ROE) compare to its peers?

As of today, AstraZeneca PLC's Return on Equity (ROE) is 20.1%, which is lower than peer median of 23.6%. The list of peers includes ABBV, LLY, AMGN, MRK, NVS, JNJ, PFE, SNY, GILD, BMY.